April 3, 2025 10:27 AM EDT
News Briefing

Moon­Lake dis­clos­es up to $500M in fi­nanc­ing; OSR’s deal with in­no­va­tion fund 

Jaimy Lee

Deputy Editor

Moon­Lake Im­munother­a­peu­tics gets fi­nanc­ing worth up to $500M: The com­pa­ny will get $75 mil­lion up­front from Her­cules Cap­i­tal. Moon­Lake, which went …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA will con­sol­i­date to five 'shared ser­vices of­fices,' ac­cord­ing to memo to Hill staffers

Roche plans Phase 3 for its lat­est Alzheimer’s drug at­tempt af­ter un­veil­ing more ear­ly da­ta

Trump has tout­ed Right to Try as a life­saver. Sev­er­al gov­ern­ment staff sup­port­ing it were just let go

Trump’s broad tar­iffs ex­empt phar­ma — but for how long?

Chaot­ic tar­iff roll­out leaves as many ques­tions as an­swers for drug­mak­ers

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times